New Rapid Learning: Fertility preservation for people with cancer

Our new mini-module and case studies will support you to understand the potential impact of cancer treatment on the fertility of people with cancer, fertility preservation options and your role in fertility preservation care.

Welcome to eviQ Education

Free, evidence-based cancer eLearning resources for health professionals.

Find out more

 

Featured Resources

Browse
  18.25hrs

Anti-cancer drug administration course

The anti-cancer drug administration course (ADAC) supports health professionals to develop the...

Last updated 04 July 2024 15:37
View details
  17.5hrs

Paediatric anti-cancer drug administration course

The anti-cancer drug administration course (ADAC) supports health professionals to develop the...

Last updated 09 May 2024 10:01
View details
  14.5hrs

Pharmacy anti-cancer drug course

The Pharmacy anti-cancer drug course supports pharmacists to develop the knowledge and clinica...

Last updated 09 May 2024 10:02
View details

Latest news

View all news

The Cancer Institute NSW has covered the cost for cancer service workers to access the LGBTQ Communities and Cancer Care course developed by ACON. Please note, there are a limited number of free registrations available.

Join eviQ teams for a virtual education event Thursday 23 May 2024 from 8.30am - 9.00am (AEST). The half hour session has been designed for nurses, and will showcase the latest national resources, clinical learning tools and free eLearning packages. There will also be dedicated time for Q&A.

The new Paediatric Anti-cancer drug administration course is now available to support health professionals develop the necessary knowledge and clinical skills to administer anti-cancer drugs and safely handle hazardous drugs and related waste.

The new Anti-cancer drug administration course is now available to support health professionals develop the necessary knowledge and clinical skills to administer anti-cancer drugs and safely handle hazardous drugs and related waste.